The report is based on the agency’s sample of nine listed hospital chains -- Apollo Hospitals, Aster DM Healthcare, Fortis Healthcare, Healthcare Global Enterprises, Krishna Institute of Medical Sciences, Max Healthcare, Narayana Hrudayalaya, Rainbow Children’s Medicare and Shalby Hospital.

Corporate hospitals to see 8-10 pc revenue growth in FY24: Report

Prabhudas Lilladher is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 345 in its research report dated August 16, 2023.

Buy Aster DM Healthcare; target of Rs 345: Prabhudas Lilladher

Aster DM Healthcare, a multi-specialty hospital chain, posted a 92.75% decline in net profit to ₹5 crore, far below the estimated ₹39.2 crore. Revenue from operations was ₹3,215.37 crore, up 20.78% YoY. India business saw 29% revenue increase and 47% EBITDA growth, while GCC saw 18% revenue growth. …

Aster DM Healthcare’s Q1 net profit drops 92.75% to ₹5 crore

Aster DM Healthcare has completed the rebranding of Dr. Ramesh Hospitals in Andhra Pradesh to Aster Ramesh Hospitals. This came after an increase in equity stake by founder-chairman Dr Azad Moopen’s family. The rebranding exercise has been completed for all four Ramesh hospitals in Andhra Pradesh, w…

Aster rebrands Andhra-based Ramesh Hospitals

Aster DM Healthcare, a Dubai-based integrated healthcare provider, is expanding its presence in southern India. They have taken over Narayanadri Hospitals in Tirupati, AP and are looking for more opportunities in Tamil Nadu. They recently rebranded Ramesh Hospitals in Vijayawada, with Aster DM ownin…

Focus on to expand footprint in south India, says Aster DM Healthcare founder-chairman Azad Moopen

Aster DM Healthcare acquires 57.5% stake in Ramesh Hospitals, adding 710 beds to its total bed count in India. Four of Ramesh Hospitals’ units will be rebranded as Aster Ramesh Hospitals. Aster DM Healthcare has 17 operational hospitals, 250 pharmacies, 2 reference labs, 20 satellite labs, 2 CPEC an…

Aster DM acquires 57.5% of Ramesh Hospitals for approx ₹200 crore

Of the nine analysts tracking the company, eight maintain a buy rating on the stock, while one recommends a hold.

Aster DM Healthcare Shares Jump Over 5% On Buying Additional Stake In Subsidiary

Reuters reported on Tuesday that private equity firm Fajr is in exclusive talks to buy a majority stake in Aster’s Gulf business, citing two sources with direct knowledge of the matter.

Aster DM Healthcare confirms talks with Fajr Capital, others on Gulf business

The 30-share BSE Sensex pack rose 85 points or 0.14 per cent to close at 63,229; while the broader NSE Nifty index moved 40 points or 0.21 per cent up to settle at 18,756. Mid and smallcap shares finished on a positive note, with the Nifty Midcap 100 up 0.21 per cent and Nifty Smallcap 100 rising 0…

Sensex rises 85 points, Nifty settles above 18,750; PCBL, Aster DM Healthcare jump up to 9%; Tata Teleservices falls 5%

Prabhudas Lilladher is bullish on Aster DM Healthcare has recommended buy rating on the stock with a target price of Rs 335 in its research report dated May 29, 2023.

Buy Aster DM Healthcare; target of Rs 335: Prabhudas Lilladher

Aster’s PAT for FY23 dropped by 19 per cent to ₹425 crore from ₹526 crore in FY22

Aster DM Healthcare’s Q4 PAT drops 24% to ₹171 crore

Price return has been average, nothing exciting

Performance

Seems to be overvalued vs the market average

Valuation

Lagging behind the market in financials growth

Growth

Showing good signs of profitability & efficiency

Profitability

The stock is overpriced but is not in the overbought zone

Current price is more than the intrinsic value

Fundamentals

Good time to consider, stock is not in the overbought zone

Technicals

Entry point

The stock has a moderate number of red flags

Promoter pledged holding

Unsolicited messages

Default probability

Red flags

Aster DM Healthcare Limited is a healthcare service provider. The Company operates in various segments of the healthcare industry, which include hospitals, clinics and retail pharmacies